Gemcitabine, oxaliplatin, and capecitabine (GEMOXEL) compared with gemcitabine alone in metastatic pancreatic cancer: a randomized phase II study

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, January 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,264 followers.

Gemcitabine, oxaliplatin, and capecitabine for advanced pancreatic cancer. Diferencias relevantes VS gem. Fase II http://t.co/A9GTXQwsIx

Fase II en CA páncreas metst: SG 11,9 meses GEMOXEL (gemcitabina, oxaliplatino, capecitabina) vs 7,1 gemcitabina sola http://t.co/29fJ3fzRdj

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.